Molecular Therapy — Oncolytics · 2018 · 38 citations · 20 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyMicrorna BiologyMicrorna-mediated RegulationOncolytic Virus TherapyTarget Site SelectionViral Rna BiologyViral VaccinesMicrorna Binding SitesMicrorna Target CleavageMicrorna TargetingMicrorna TherapeuticsOncolytic Viral VectorsOncolytic Virus VaccinesTarget Site ModificationViral Untranslated Regions
genes and generated viruses harboring microRNA target sites in multiple genes. We report critical importance of target-site positioning with proximal genomic positions effecting maximum vector control. No relevant additional effect of six versus three miRTS copies for the same microRNA species in terms of regulatory efficiency was observed. Moreover, we demonstrate that, depending on the microRNA species, viral mRNAs containing microRNA target sites are directly cleaved and/or translationally repressed in presence of cognate microRNAs. In conclusion, we report highly efficient control of measles virus replication with various miRTS positions for development of safe and efficient cancer virotherapy and provide insights into the mechanisms underlying microRNA-mediated vector control.
20
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Pablo Landgraf, Mirabela Rusu, Robert P. Sheridan et al. · Cell · 2007 · 3.7K citations · Full text
Rescue of measles viruses from cloned DNA.
Frank Radecke, Pius Spielhofer, Henriette Schneider et al. · The EMBO Journal · 1995 · 637 citations · Full text
First oncolytic virus approved for melanoma immunotherapy
Jonathan Pol, Guido Kroemer, Lorenzo Galluzzi · OncoImmunology · 2015 · 375 citations · Full text
Medicine, Immunology, Oncology +17